Secrets of Building an AI x Bio Company

​You can now build proteins that have never existed. That single shift breaks almost every old playbook for starting a bio company - and traps most founders in a choice they don’t need to make.

​In this talk, Alex shares hard-won lessons from founders building at the intersection of AI and biology - from Manifold Bio and Nabla Bio to Plasmidsaurus, Latch, and Elicit.

​Come learn:

• ​Why the “platform or asset” question traps most AI-bio founders, and how to sidestep it

• ​What biotech VCs and public markets actually reward, and what they quietly punish

• ​How to prove your technology and earn real traction before staking the company on a single drug

• ​When to start building assets, and how to fund them on your own terms

​Come for an honest, founder-first perspective on building an indispensable company as AI rewrites what’s possible in biology. Whether you’re deep in the lab or just beginning to sketch an idea, we’ll see you at Baker Lab on July 29.